Journal article
Left ventricular hypertrophy in experimental chronic kidney disease is associated with reduced expression of cardiac Kruppel-like factor 15
SK Patel, E Velkoska, D Gayed, J Ramchand, J Lesmana, LM Burrell
BMC Nephrology | BMC | Published : 2018
Open access
Abstract
Background: Left ventricular hypertrophy (LVH) increases the risk of death in chronic kidney disease (CKD). The transcription factor Kruppel-like factor 15 (KLF15) is expressed in the heart and regulates cardiac remodelling through inhibition of hypertrophy and fibrosis. It is unknown if KLF15 expression is changed in CKD induced LVH, or whether expression is modulated by blood pressure reduction using angiotensin converting enzyme (ACE) inhibition. Methods: CKD was induced in Sprague-Dawley rats by subtotal nephrectomy (STNx), and rats received vehicle (n = 10) or ACE inhibition (ramipril, 1 mg/kg/day, n = 10) for 4 weeks. Control, sham-operated rats (n = 9) received vehicle. Cardiac struct..
View full abstractGrants
Awarded by Sir Edward Dunlop Medical Research Foundation
Funding Acknowledgements
The work was supported by a National Health and Medical Research Council Grant (APP1048285); a Career Development Award (SKP), University of Melbourne and a Sir Edward Dunlop Medical Research Foundation grant (SKP).